These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 26822015

  • 1. On the analysis of clonogenic survival data: Statistical alternatives to the linear-quadratic model.
    Unkel S, Belka C, Lauber K.
    Radiat Oncol; 2016 Jan 28; 11():11. PubMed ID: 26822015
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cell survival and radiosensitisation: modulation of the linear and quadratic parameters of the LQ model (Review).
    Franken NA, Oei AL, Kok HP, Rodermond HM, Sminia P, Crezee J, Stalpers LJ, Barendsen GW.
    Int J Oncol; 2013 May 28; 42(5):1501-15. PubMed ID: 23503754
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A LQ-based kinetic model formulation for exploring dynamics of treatment response of tumours in patients.
    Scheidegger S, Lutters G, Bodis S.
    Z Med Phys; 2011 Sep 28; 21(3):164-73. PubMed ID: 21237624
    [Abstract] [Full Text] [Related]

  • 10. Fitting the linear-quadratic model to detailed data sets for different dose ranges.
    Garcia LM, Leblanc J, Wilkins D, Raaphorst GP.
    Phys Med Biol; 2006 Jun 07; 51(11):2813-23. PubMed ID: 16723768
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery.
    Kirkpatrick JP, Meyer JJ, Marks LB.
    Semin Radiat Oncol; 2008 Oct 07; 18(4):240-3. PubMed ID: 18725110
    [Abstract] [Full Text] [Related]

  • 16. Predicting the clonogenic survival of A549 cells after modulated x-ray irradiation using the linear quadratic model.
    Bromley R, Oliver L, Davey R, Harvie R, Baldock C.
    Phys Med Biol; 2009 Jan 21; 54(2):187-206. PubMed ID: 19088388
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy.
    Park C, Papiez L, Zhang S, Story M, Timmerman RD.
    Int J Radiat Oncol Biol Phys; 2008 Mar 01; 70(3):847-52. PubMed ID: 18262098
    [Abstract] [Full Text] [Related]

  • 19. Applicability of the linear-quadratic model to single and fractionated radiotherapy schedules: an experimental study.
    Miyakawa A, Shibamoto Y, Otsuka S, Iwata H.
    J Radiat Res; 2014 May 01; 55(3):451-4. PubMed ID: 24351457
    [Abstract] [Full Text] [Related]

  • 20. Effect of patient variation on standard- and hypo-fractionated radiotherapy of prostate cancer.
    Xiong W, Li J, Ma CM.
    Phys Med Biol; 2005 Apr 07; 50(7):1483-92. PubMed ID: 15798338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.